The tacrolimus metabolism rate influences renal function after kidney transplantation.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4207775)

Published in PLoS One on October 23, 2014

Authors

Gerold Thölking1, Christian Fortmann1, Raphael Koch2, Hans Ulrich Gerth1, Dirk Pabst1, Hermann Pavenstädt1, Iyad Kabar3, Anna Hüsing3, Heiner Wolters4, Stefan Reuter1, Barbara Suwelack1

Author Affiliations

1: Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, Münster, Germany.
2: Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
3: Department of Transplant Medicine, University Hospital of Münster, Münster, Germany.
4: Department of General Surgery, University Hospital of Münster, Münster, Germany.

Associated clinical trials:

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients | NCT04469842

Tacrolimus Pharmacokinetic Subpopulations (TIPS) | NCT04526431

Articles cited by this

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44

The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant (2009) 1.88

Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Transplantation (2012) 1.58

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant (2003) 1.34

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther (2007) 1.23

The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant (2007) 0.97

The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation. Eur J Clin Pharmacol (2011) 0.96

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring. Ann Transplant (2008) 0.96

Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes. Clin Chem Lab Med (2011) 0.93

Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. Transplantation (2011) 0.92

Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant (2007) 0.91

Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J Heart Lung Transplant (2011) 0.90

Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation (2013) 0.88

The rate of gastric emptying determines the timing but not the extent of oral tacrolimus absorption: simultaneous measurement of drug exposure and gastric emptying by carbon-14-octanoic acid breath test in stable renal allograft recipients. Drug Metab Dispos (2004) 0.85

Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. Transplantation (2012) 0.85

Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation (2004) 0.84

BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes? Ann Transplant (2012) 0.84

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function. Clin Chem Lab Med (2006) 0.84

Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. Basic Clin Pharmacol Toxicol (2012) 0.82

Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplant Proc (2003) 0.81

Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus. Transplantation (2013) 0.80

Enteric absorption of FK 506: estimation by a block liver perfusion technique in rats. Transplant Proc (1998) 0.80